Phosphocaveolin-1 enforces tumor growth and chemoresistance in rhabdomyosarcoma.
Caveolin-1 (Cav-1) can ambiguously behave as either tumor suppressor or oncogene depending on its phosphorylation state and the type of cancer. In this study we show that Cav-1 was phosphorylated on tyrosine 14 (pCav-1) by Src-kinase family members in various human cell lines and primary mouse cultu...
Guardado en:
| Autores principales: | , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Public Library of Science (PLoS)
2014
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/ddcb29e0392d48e6817da1a721921f77 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:ddcb29e0392d48e6817da1a721921f77 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:ddcb29e0392d48e6817da1a721921f772021-11-18T08:38:02ZPhosphocaveolin-1 enforces tumor growth and chemoresistance in rhabdomyosarcoma.1932-620310.1371/journal.pone.0084618https://doaj.org/article/ddcb29e0392d48e6817da1a721921f772014-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24427291/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203Caveolin-1 (Cav-1) can ambiguously behave as either tumor suppressor or oncogene depending on its phosphorylation state and the type of cancer. In this study we show that Cav-1 was phosphorylated on tyrosine 14 (pCav-1) by Src-kinase family members in various human cell lines and primary mouse cultures of rhabdomyosarcoma (RMS), the most frequent soft-tissue sarcoma affecting childhood. Cav-1 overexpression in the human embryonal RD or alveolar RH30 cells yielded increased pCav-1 levels and reinforced the phosphorylation state of either ERK or AKT kinase, respectively, in turn enhancing in vitro cell proliferation, migration, invasiveness and chemoresistance. In contrast, reducing the pCav-1 levels by administration of a Src-kinase inhibitor or through targeted Cav-1 silencing counteracted the malignant in vitro phenotype of RMS cells. Consistent with these results, xenotransplantation of Cav-1 overexpressing RD cells into nude mice resulted in substantial tumor growth in comparison to control cells. Taken together, these data point to pCav-1 as an important and therapeutically valuable target for overcoming the progression and multidrug resistance of RMS.Fiorella FaggiStefania MitolaGuglielmo SorciFrancesca RiuzziRosario DonatoSilvia CodenottiPietro Luigi PolianiManuela CominelliRaffaella VescoviStefania RossiStefano CalzaMarina ColombiFabio PennaPaola CostelliIlaria PeriniMaurilio SampaolesiEugenio MontiAlessandro FanzaniPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 9, Iss 1, p e84618 (2014) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine R Science Q |
| spellingShingle |
Medicine R Science Q Fiorella Faggi Stefania Mitola Guglielmo Sorci Francesca Riuzzi Rosario Donato Silvia Codenotti Pietro Luigi Poliani Manuela Cominelli Raffaella Vescovi Stefania Rossi Stefano Calza Marina Colombi Fabio Penna Paola Costelli Ilaria Perini Maurilio Sampaolesi Eugenio Monti Alessandro Fanzani Phosphocaveolin-1 enforces tumor growth and chemoresistance in rhabdomyosarcoma. |
| description |
Caveolin-1 (Cav-1) can ambiguously behave as either tumor suppressor or oncogene depending on its phosphorylation state and the type of cancer. In this study we show that Cav-1 was phosphorylated on tyrosine 14 (pCav-1) by Src-kinase family members in various human cell lines and primary mouse cultures of rhabdomyosarcoma (RMS), the most frequent soft-tissue sarcoma affecting childhood. Cav-1 overexpression in the human embryonal RD or alveolar RH30 cells yielded increased pCav-1 levels and reinforced the phosphorylation state of either ERK or AKT kinase, respectively, in turn enhancing in vitro cell proliferation, migration, invasiveness and chemoresistance. In contrast, reducing the pCav-1 levels by administration of a Src-kinase inhibitor or through targeted Cav-1 silencing counteracted the malignant in vitro phenotype of RMS cells. Consistent with these results, xenotransplantation of Cav-1 overexpressing RD cells into nude mice resulted in substantial tumor growth in comparison to control cells. Taken together, these data point to pCav-1 as an important and therapeutically valuable target for overcoming the progression and multidrug resistance of RMS. |
| format |
article |
| author |
Fiorella Faggi Stefania Mitola Guglielmo Sorci Francesca Riuzzi Rosario Donato Silvia Codenotti Pietro Luigi Poliani Manuela Cominelli Raffaella Vescovi Stefania Rossi Stefano Calza Marina Colombi Fabio Penna Paola Costelli Ilaria Perini Maurilio Sampaolesi Eugenio Monti Alessandro Fanzani |
| author_facet |
Fiorella Faggi Stefania Mitola Guglielmo Sorci Francesca Riuzzi Rosario Donato Silvia Codenotti Pietro Luigi Poliani Manuela Cominelli Raffaella Vescovi Stefania Rossi Stefano Calza Marina Colombi Fabio Penna Paola Costelli Ilaria Perini Maurilio Sampaolesi Eugenio Monti Alessandro Fanzani |
| author_sort |
Fiorella Faggi |
| title |
Phosphocaveolin-1 enforces tumor growth and chemoresistance in rhabdomyosarcoma. |
| title_short |
Phosphocaveolin-1 enforces tumor growth and chemoresistance in rhabdomyosarcoma. |
| title_full |
Phosphocaveolin-1 enforces tumor growth and chemoresistance in rhabdomyosarcoma. |
| title_fullStr |
Phosphocaveolin-1 enforces tumor growth and chemoresistance in rhabdomyosarcoma. |
| title_full_unstemmed |
Phosphocaveolin-1 enforces tumor growth and chemoresistance in rhabdomyosarcoma. |
| title_sort |
phosphocaveolin-1 enforces tumor growth and chemoresistance in rhabdomyosarcoma. |
| publisher |
Public Library of Science (PLoS) |
| publishDate |
2014 |
| url |
https://doaj.org/article/ddcb29e0392d48e6817da1a721921f77 |
| work_keys_str_mv |
AT fiorellafaggi phosphocaveolin1enforcestumorgrowthandchemoresistanceinrhabdomyosarcoma AT stefaniamitola phosphocaveolin1enforcestumorgrowthandchemoresistanceinrhabdomyosarcoma AT guglielmosorci phosphocaveolin1enforcestumorgrowthandchemoresistanceinrhabdomyosarcoma AT francescariuzzi phosphocaveolin1enforcestumorgrowthandchemoresistanceinrhabdomyosarcoma AT rosariodonato phosphocaveolin1enforcestumorgrowthandchemoresistanceinrhabdomyosarcoma AT silviacodenotti phosphocaveolin1enforcestumorgrowthandchemoresistanceinrhabdomyosarcoma AT pietroluigipoliani phosphocaveolin1enforcestumorgrowthandchemoresistanceinrhabdomyosarcoma AT manuelacominelli phosphocaveolin1enforcestumorgrowthandchemoresistanceinrhabdomyosarcoma AT raffaellavescovi phosphocaveolin1enforcestumorgrowthandchemoresistanceinrhabdomyosarcoma AT stefaniarossi phosphocaveolin1enforcestumorgrowthandchemoresistanceinrhabdomyosarcoma AT stefanocalza phosphocaveolin1enforcestumorgrowthandchemoresistanceinrhabdomyosarcoma AT marinacolombi phosphocaveolin1enforcestumorgrowthandchemoresistanceinrhabdomyosarcoma AT fabiopenna phosphocaveolin1enforcestumorgrowthandchemoresistanceinrhabdomyosarcoma AT paolacostelli phosphocaveolin1enforcestumorgrowthandchemoresistanceinrhabdomyosarcoma AT ilariaperini phosphocaveolin1enforcestumorgrowthandchemoresistanceinrhabdomyosarcoma AT mauriliosampaolesi phosphocaveolin1enforcestumorgrowthandchemoresistanceinrhabdomyosarcoma AT eugeniomonti phosphocaveolin1enforcestumorgrowthandchemoresistanceinrhabdomyosarcoma AT alessandrofanzani phosphocaveolin1enforcestumorgrowthandchemoresistanceinrhabdomyosarcoma |
| _version_ |
1718421531664580608 |